mBank S.A.
mBank S.A. (BREJY) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for mBank S.A. (BREJY), covering cash flow, earnings, and balance sheets.
mBank S.A. (BREJY) Income Statement & Financial Overview
Analyze mBank S.A.’s BREJY earnings with segmented quarterly and yearly financial statement figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $3.09B | $3.15B | $4.79B | $4.20B |
Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Gross Profit | $3.09B | $3.15B | $4.79B | $4.20B |
Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $139.87M | $188.14M | $259.83M | $642.28M |
Operating Expenses | $1.26B | $1.21B | $3.19B | $557.14M |
Total Costs & Expenses | $1.26B | $1.21B | $3.19B | $2.46B |
Interest Income | $3.61B | $3.77B | $3.83B | $3.35B |
Interest Expense | $1.17B | $1.26B | $1.25B | $1.18B |
Depreciation & Amortization | $148.37M | $168.83M | $148.72M | $144.82M |
EBITDA | $0.00 | $0.00 | $1.13B | $0.00 |
EBITDA Ratio | $0.00 | $0.00 | $0.24 | $0.00 |
Operating Income | $1.83B | $1.95B | $1.13B | $1.75B |
Operating Income Ratio | $0.59 | $0.62 | $0.24 | $0.42 |
Other Income/Expenses (Net) | -$841.83M | -$1.11B | -$148.72M | -$1.03B |
Income Before Tax | $989.46M | $837.73M | $984.006M | $719.29M |
Income Before Tax Ratio | $0.32 | $0.27 | $0.21 | $0.17 |
Income Tax Expense | $283.79M | -$148.28M | $411.10M | $297.40M |
Net Income | $705.67M | $986.002M | $572.86M | $421.86M |
Net Income Ratio | $0.23 | $0.31 | $0.12 | $0.10 |
EPS | $16.61 | $23.20 | $13.48 | $9.93 |
Diluted EPS | $16.58 | $23.17 | $13.48 | $9.93 |
Weighted Avg Shares Outstanding | $42.50M | $42.50M | $42.50M | $42.50M |
Weighted Avg Shares Outstanding (Diluted) | $42.57M | $42.56M | $42.50M | $42.50M |
Over the past four quarters, mBank S.A. demonstrated steady revenue growth, increasing from $4.20B in Q2 2024 to $3.09B in Q1 2025. Operating income reached $1.83B in Q1 2025, maintaining a consistent 59% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $0.00, reflecting operational efficiency. Net income dropped to $705.67M, with EPS at $16.61. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan